Literature DB >> 8134632

The development of antibody to Cowdria ruminantium in mice and its role in heartwater disease.

B Byrom1, S M Mahan, A F Barbet.   

Abstract

DBA/2 and Balb/c mice were used as a model to study the immune responses to Cowdria ruminantium. Both strains of mice were inoculated with 1, 10 or 100 LD50 of the Crystal Springs strain of C. ruminantium. Antibody to C. ruminantium started to develop in the second week post-inoculation and the titre of the antibody was dependent on the inoculation dose of C. ruminantium. The possible role of antibody in heartwater disease was studied by in vitro neutralization assays using both mouse sera and bovine sera. Results of these tests show that hyperimmune serum from both DBA/2 and Balb/c mice had the ability to neutralize infection in vitro, with the DBA/2 serum showing a greater neutralizing effect. Two bovine sera, one from a laboratory infected animal and one a pool from two animals infected in the field also gave a neutralizing effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8134632

Source DB:  PubMed          Journal:  Rev Elev Med Vet Pays Trop        ISSN: 0035-1865


  4 in total

1.  Immunization of cattle by infection with Cowdria ruminantium elicits T lymphocytes that recognize autologous, infected endothelial cells and monocytes.

Authors:  D M Mwangi; S M Mahan; J K Nyanjui; E L Taracha; D J McKeever
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Analysis of T-cell responses in cattle immunized against heartwater by vaccination with killed elementary bodies of Cowdria ruminantium.

Authors:  P Totté; D McKeever; D Martinez; A Bensaid
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 3.  Progress and obstacles in vaccine development for the ehrlichioses.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

4.  Mechanisms of immunity to Ehrlichia muris: a model of monocytotropic ehrlichiosis.

Authors:  Hui-Min Feng; David H Walker
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.